BIOMAT Database Logo BIOMAT Database Logo

Interleukin-2 enhances angiogenesis and preserves cardiac function following myocardial infarction. 2011

M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, 3755 Cote Ste-Catherine Road, Montreal, Quebec, Canada H3T 1E2.

We previously demonstrated that injection of IL-2-activated natural killer (NK) cells contribute to vascular remodeling via a4b7 integrin and killer cell lectin-like receptor (KLRG) 1 and promote cardiac repair following myocardial infarction (MI). The aim of the present study is to test the hypothesis that injection of recombinant human interleukin (rhIL)-2 improves angiogenesis and preserves heart function after MI. A single IV injection of rhIL-2 two days following MI improved by 27.7% the left ventricular (LV) fractional shortening of immune competent (C57Bl6) mice, but had no effect on cardiac function of immune-deficient (NOD-SCID IL2RĪ³null) mice. Immunohistochemical analysis of C57Bl6 cross sections of heart revealed that collagen deposition was reduced by 23.1% and that capillary density was enhanced in the scar area and the border zone of the infarct respectively by 22.4% and 33.6% following rhIL-2 injection. In addition, rhIL-2 enhanced 1.6-fold the in vivo endothelial cell proliferation index and 1.8-fold the number of NK cell infiltrating the infarcted heart, but had no effect on the number of cardiac CD4 and CD8 cells. In vitro, rhIL-2 activated NK cells enhanced cardiac endothelial cell proliferation by 17.2%. Here we show that a single IV injection of rhIL-2 positively impacted cardiac function by improving angiogenesis through a process involving NK cells.

UI MeSH Term Description Entries
D007376 Interleukin-2 A soluble substance elaborated by antigen- or mitogen-stimulated T-LYMPHOCYTES which induces DNA synthesis in naive lymphocytes. IL-2,Lymphocyte Mitogenic Factor,T-Cell Growth Factor,TCGF,IL2,Interleukin II,Interleukine 2,RU 49637,RU-49637,Ro-23-6019,Ro-236019,T-Cell Stimulating Factor,Thymocyte Stimulating Factor,Interleukin 2,Mitogenic Factor, Lymphocyte,RU49637,Ro 23 6019,Ro 236019,Ro236019,T Cell Growth Factor,T Cell Stimulating Factor
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D009929 Organ Size The measurement of an organ in volume, mass, or heaviness. Organ Volume,Organ Weight,Size, Organ,Weight, Organ
D002452 Cell Count The number of CELLS of a specific kind, usually measured per unit volume or area of sample. Cell Density,Cell Number,Cell Counts,Cell Densities,Cell Numbers,Count, Cell,Counts, Cell,Densities, Cell,Density, Cell,Number, Cell,Numbers, Cell
D003094 Collagen A polypeptide substance comprising about one third of the total protein in mammalian organisms. It is the main constituent of SKIN; CONNECTIVE TISSUE; and the organic substance of bones (BONE AND BONES) and teeth (TOOTH). Avicon,Avitene,Collagen Felt,Collagen Fleece,Collagenfleece,Collastat,Dermodress,Microfibril Collagen Hemostat,Pangen,Zyderm,alpha-Collagen,Collagen Hemostat, Microfibril,alpha Collagen
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006321 Heart The hollow, muscular organ that maintains the circulation of the blood. Hearts

Related Publications

M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
Morroniside enhances angiogenesis and improves cardiac function following acute myocardial infarction in rats.
April 2020, European journal of pharmacology,
M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
OSM Enhances Angiogenesis and Improves Cardiac Function after Myocardial Infarction.
January 2015, BioMed research international,
M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
Calpain inhibition preserves myocardial structure and function following myocardial infarction.
November 2009, American journal of physiology. Heart and circulatory physiology,
M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
Atglistatin Pretreatment Preserves Remote Myocardium Function Following Myocardial Infarction.
May 2021, Journal of cardiovascular pharmacology and therapeutics,
M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
Atorvastatin enhances interleukin-10 levels and improves cardiac function in rats after acute myocardial infarction.
January 2009, Clinical science (London, England : 1979),
M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
S100A1 gene therapy preserves in vivo cardiac function after myocardial infarction.
December 2005, Molecular therapy : the journal of the American Society of Gene Therapy,
M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
Gelatin Hydrogel Enhances the Engraftment of Transplanted Cardiomyocytes and Angiogenesis to Ameliorate Cardiac Function after Myocardial Infarction.
January 2015, PloS one,
M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
Targeted gene deletion of prolyl hydroxylase domain protein 3 triggers angiogenesis and preserves cardiac function by stabilizing hypoxia inducible factor 1 alpha following myocardial infarction.
January 2014, Current pharmaceutical design,
M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction.
January 2012, PloS one,
M Bouchentouf, and P Williams, and K A Forner, and J Cuerquis, and V Michaud, and P Paradis, and E L Schiffrin, and J Galipeau
Cortical Bone Stem Cell Therapy Preserves Cardiac Structure and Function After Myocardial Infarction.
November 2017, Circulation research,
Copied contents to your clipboard!